Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fransen

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Human Molecular Genetics|June 13, 1998
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patternsE Fransen, R D'Hooge, G Van Camp, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 23, 2018
Prostate sparing cystectomy for bladder cancer: A two-center studyCharlotte S Voskuilen, Elisabeth E Fransen van de Putte, Jose I Pérez-Reggeti, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal RemodelingEileen Miller, Alicja Czopek, Karolina M Duthie, et al.
The Journal of Urology|October 16, 2018
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder CancerElisabeth E Fransen van de Putte, Floris Pos, Barry Doodeman, et al.
The Journal of Urology|June 18, 2016
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant ChemotherapyWilhelmina C M Duivenvoorden, Siamak Daneshmand, Daniel Canter, et al.
European Urology|February 1, 2015
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant ChemotherapyFloris H Groenendijk, Jeroen de Jong, Elisabeth E Fransen van de Putte, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
European Urology Open Science|January 15, 2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy TrialsLeo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Journal of Medical Genetics|May 19, 2001
A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutationE Fransen, M Verstreken, S J Bom, et al.
BJU International|April 12, 2018
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancerElisabeth E Fransen van de Putte, Judith Bosschieter, Theo H van der Kwast, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Human Molecular Genetics|June 13, 1998
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patternsE Fransen, R D'Hooge, G Van Camp, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 23, 2018
Prostate sparing cystectomy for bladder cancer: A two-center studyCharlotte S Voskuilen, Elisabeth E Fransen van de Putte, Jose I Pérez-Reggeti, et al.
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal RemodelingEileen Miller, Alicja Czopek, Karolina M Duthie, et al.
The Journal of Urology|October 16, 2018
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder CancerElisabeth E Fransen van de Putte, Floris Pos, Barry Doodeman, et al.
The Journal of Urology|June 18, 2016
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant ChemotherapyWilhelmina C M Duivenvoorden, Siamak Daneshmand, Daniel Canter, et al.
European Urology|February 1, 2015
ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant ChemotherapyFloris H Groenendijk, Jeroen de Jong, Elisabeth E Fransen van de Putte, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
European Urology Open Science|January 15, 2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy TrialsLeo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Journal of Medical Genetics|May 19, 2001
A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutationE Fransen, M Verstreken, S J Bom, et al.
BJU International|April 12, 2018
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancerElisabeth E Fransen van de Putte, Judith Bosschieter, Theo H van der Kwast, et al.
Pageof 13